Immunify.Life Successfully Closes Initial Fundraising Rounds Securing $2M from Blue-Chip Blockchain VCs

The funds will be used to implement in-country fieldwork to address global challenges including HIV treatment rates and vaccination management in Africa

The funds will be used to implement in-country fieldwork to address global challenges including HIV treatment rates and vaccination management in Africa

Sydney, Australia, Sept. 16, 2022 (GLOBE NEWSWIRE) --

Immunify.Life, the transformative and self-sustaining healthcare ecosystem secured by blockchain, is proud to announce the successful closure of its seed and private investment rounds. The platform raised approximately $2M from widely recognized and respected investors in the blockchain and digital transformation spaces, including BluFolio, a Switzerland-based blockchain VC.

Immunify.Life CEO Guy Newing commented on the partnership by saying: “Immunify.Life is built to address the many challenges of HIV, AIDS, tuberculosis, and other vaccination programs. With blockchain-based functionality that can revolutionize healthcare services provision in Africa and beyond, we are committed to improving patient health outcomes using science, innovation, and technology. With this new funding round, we are that much closer to making these benefits a reality.”

Founding partner at BluFolio AG James Dougall also commented on the partnership and said: “Blufolio invests today at the confluence of blockchain opportunity and sustainability initiatives. We are passionate believers that digital and blockchain technologies are driving unprecedented innovation. Immunify.Life represents one of the key verticals we look at healthtech specifically the Cardano blockchain, and digital health to...



source: https://www.globenewswire.com/news-release/2022/09/16/2517802/0/en/Immunify-Life-Successfully-Closes-Initial-Fundraising-Rounds-Securing-2M-from-Blue-Chip-Blockchain-VCs.html

Your content is great. However, if any of the content contained herein violates any rights of yours, including those of copyright, please contact us immediately by e-mail at media[@]kissrpr.com.



Source: Throne PR
Release ID: 379396
Tags: